the estrogen group in the mature adult (day 160). Levels of AR and ER ␤ mRNAs in the estrogen group were significantly lower in middle-aged rats (day 180). Conclusion: Estrogen exposure in the neonatal period to Wistar rats decreases the number of ER ␤ in the mature adult and accelerates cell proliferation.
characteristics. We reported previously that estradiol/ free testosterone (E2/free-T) ratios were significantly higher in males receiving hemodialysis than in healthy men [5] . Notwithstanding, it is evidenced that neither estrogen nor aging affect progression of BPH in males on hemodialysis.
There are differences in prostate growth and area density of components in the hyperplastic prostate not only between races but also within one race [6, 7] .
Attention has been focused on the effects of environmental endocrine disruptors on the male reproductive system so far, but little is known about whether these contaminants may influence prostate growth [8] [9] [10] [11] [12] . Weihua et al. [13] reported an increased epithelial component of ventral prostate in ER ␤ -KO mice.
We attempted to elucidate whether these differences in prostate components were attributed to the exposure of environmental disrupters during the neonatal period. We also investigated the period conducive to prostate enlargement in these rats which were exposed during their neonatal period.
Materials and Methods

Animals
Neonatal male Wister rats were used. Each 64 rats were given an injection of estradiol benzoate (EB) at a dose of 25 g (neonatal estrogen exposure group) or oil without EB (control group) on days 1, 3 and 5 after birth [11] . Each group of rats was divided into four subgroups and sacrificed on days 80, 120, 160 and 180.
Their blood samples were also collected for testosterone assay.
The excised ventral prostate tissue was either fixed in 10% formalin buffer or frozen immediately under liquid nitrogen for histological study or hormonal and molecular assay, respectively.
Determination of Serum Testosterone
After addition of 2 ng of testosterone-19-C 2 H 3 (T-d3) to the serum as an internal standard, the serum was applied to a Bond Elut C18 cartridge column (3 ML; Vartian, Harbor, Calif., USA). Testosterone was eluted with 70% acetonitrile/water and then the relevant fractions were evaporated under reduced pressure. The dried extract was reacted with 100 l of carboxymethoxylamine hemihydrochloride (CMA) solution overnight in the dark at room temperature. Subsequently, the resultant CMA derivatives were dried under nitrogen gas at 45 ° C and redissolved and applied to a Bond Elut C18 cartridge column. The steroid fraction was eluted with methanol/water (2: 1) and evaporated to dryness under reduced pressure using a centrifugal evaporator at 45 ° C and stored at -20 ° C until analysis.
The samples were then dissolved in solvent for HPLC, and applied onto a liquid chromatography-tandem mass spectrometry (LC-MS/MS) instrument (Micromass Qattro II interfaced to a Hewlett Packard HP 1100, Corvallis, Oreg., USA). The molecular ion mass of m/z 360.20 was cleaved again and the derived molecular ion mass of m/z 286.20 was monitored. The testosterone quantity was measured by relating the peak areas of analyte steroid to the peak areas of the internal standards (the molecular ion mass of m/z 363.20 was cleaved, and the derived molecular ion mass of m/z 289.20 was monitored). The assay was validated to ensure that the result was within the 20% range of accuracy and precision [14] .
Quantitative Analysis of Testosterone Concentrations in the Prostate
The prostate tissue was pulverized completely to powder in liquid nitrogen, weighed and transferred to a 30-ml glass tube and homogenized with an Ultra-Turrax homogenizer (Junke and Kunkel, Germany). The steroid was extracted with 40% ethylacetate/hexane (20 ml), and the organic layer was washed repeatedly with 5% NaHCO 3 and dried over Na 2 SO 4 . After evaporation, the residue was dissolved in 1 ml of 30% acetonitrile/water, and then the solution was applied to a Bond Elut C18 cartridge column. The column was washed with 1 ml of 30% acetonitrile/water, and the steroid fraction was eluted with 70% acetonitrile/water. The obtained steroid extract was evaporated under reduced pressure. The dried extract was reacted with 100 l of carboxymethoxylamine hemihydrochloride (CMA) solution and the testosterone quantity was measured by LC-MS/MS as described previously. The assay was validated to insure that the result was within the 20% range of accuracy and precision. Details of the testosterone quantification analysis were reported previously by Shibata [14] .
Real-Time Quantitative PCR of Androgen Receptor (AR) and Estrogen Receptor-␤ (ER ␤ ) mRNA
Total RNA was extracted using the RNeasy kit according to the manufacturers' protocol. Extracted RNA was treated with DNase I (Gibco BRL, Rockville, Md., USA) at room temperature for 15 min and purified using the RNeasy kit (Qiagen). cDNA was produced by the obtained RNA using TaqMan Reverse Transcription Resgents (PE Applied Biosystems, Foster City, Calif., USA). RNA (1 g) was mixed with 10 ! RT buffer (5 l), 2.5 m M dNTPs (10 l), 25 m M MgCl 2 (11 l), 12.5 M random hexamers (2.5 l), 20 U/ l RNase inhibitor (1 l) and 50 U/ l RT (1.25 l) to make the final volume 50 l. The reaction mixtures were subjected to the following amplification scheme: one cycle at 25 ° C for 10 min and one cycle at 48 ° C for 30 min, followed by one cycle at 95 ° C for 5 min.
For AR and ER-␤ , quantification of transcript copy number was performed by the dual-labeled fluorogenic probe method, using a Prism 7700 thermal cycle and sequence detector (PE Applied Biosystems). cDNA (10 ng) was mixed with 2 ! TaqMan universal PCR master mix (12.5 l), 200 n M primer (forward and reverse) and 200 n M fluorescent probe with a final volume of 25 l. The forward primer of AR was 5 -gaggcacctttctcaagagtttg-3 , while the reverse primer was 5 -aagtccacgctcaccatatgg-3 , and the probe was 5 -cgcttctaccagctcaccaa-gctcct-3 . The forward primer of ER-␤ was 5 -gctcctctatgcagaacctcaa-3 , the reverse primer was 5 -acgccgtaatgatacccagatg-3 , and the probe was 5 -cagttgtgccagccctgttactagtcca-3 . 18 s rRNA was used as an internal control of expression levels. The reaction mixtures were subjected to the following amplification scheme: one cycle at 50 ° C for 2 min (AmpErase UNG deactivation) and one cycle at 95 ° C for 10 min (Amplitaq Gold activation), followed by 50 cycles at 95 ° C (denaturation) for 15 s and 60 ° C (annealing and extension) for 1 min. Real-time PCR data were analyzed using the Sequence Detection Systems 1.6.3 (PE Applied Biosystems). In parallel with experimental samples, standard curves for AR and ER-␤ of known concentrations were quantified and absolute copy numbers were calculated. PCR products of AR and ER-␤ were TA cloned into pCR2.1 (Invitrogen, Carlsbad, Calif., USA) and sequences were confirmed using ABI 310. Obtained vectors were used for standard curve generation [15] [16] [17] [18] .
Morphometry
The prostate specimens for morphometry were fixed in 10% phosphate-buffered formalin and dehydrated through graded alcohols before being embedded in paraffin and divided into 4-mthick sections. All of the sections were processed with HE stain for pathological diagnosis and quantitative morphometric analysis.
All HE specimens were examined by one pathologist to ensure that prostate cancer and prostatitis were not present. Quantitative morphometric analysis was performed using light-microscopic stereological analysis at a magnification of 400 ! [19, 20] . The area was classified by the following tissue components: smooth muscle cells (SM), connective tissue (CT), glandular epithelium (GE), glandular lumen (GL), and vascular lumen (V). Stromal component was defined as the sum of SM and CT, and glandular component as the sum of GE and GL. The total area occupied by each category was determined using a computerized digital morphometric analysis system (Adobe Photoshop 4.0J and NIH Image 1.61) on a Macintosh G4 microcomputer. At least 100 systematic test areas were analyzed from all of the resected specimens. Using the stereological principle, area distribution was proportional to volume distribution [21] .
Immunohistochemical Analysis of Proliferating Cell Nuclear Antigen (PCNA)
Prostate specimens were fixed in paraffin in a similar manner to that described for morphometry. The tissue sections were deparaffinized and rehydrated, incubated with 3% hydrogen peroxide in distilled water for 5 min, rinsed with distilled water and placed in Tris-buffered saline (TBS: 0.05 mol/l Tris-HCl, 0.15 mol/l NaCl, pH 7.6) for 5 min. The specimens were then covered with 2 drops (one drop equals 50 l) of monoclonal mouse anti-PCNA, coupled with horseradish peroxidase (DAKO EPOS Anti-PCNA/HRP) and incubated for 60 min at room temperature. After rinsing in TBS for 5 min, they were incubated with 3,3 -diaminobenzidine tetra-hydrochloride (DAB), followed by rinsing with distilled water, then counterstained with HE and mounted on a coverslip. The positive rate of anti-PCNA stained cells was measured quantitatively using light-microscopic stereological analysis at a magnification of 400 ! and NIH image 1.61. At least 100 systematic test areas were analyzed from all of the resected specimens. The PCNA staining cell ratio was defined as a percentage of PCNA-staining cells in all the epithelial cells.
Statistical Analysis
All results are expressed as mean 8 SD. Two-group comparisons were analyzed by Mann-Whitney's U test. The level of significance was set at p ! 0.05.
Results
Tissue Weights
Neonatal estrogen exposure provided no influence on reproductive organ abnormality. In the neonatal estrogen exposure group, the ratio of the ventral prostate weight/ body weight (ventral/BW) was significantly decreased on days 80 and 180 ( fig. 1 a) .
Serum Testosterone
Serum testosterone concentration was significantly lower in the neonatal exposure group on day 120, but no differences were found between the two groups on the other days of observation ( fig. 1 b) .
Tissue Testosterone
Tissue testosterone concentration was significantly lower in the neonatal exposure group on day 120, whereas the concentration was significantly higher in the neonatal exposure group on day 180 ( fig. 1 c) .
AR mRNA Concentration AR concentrations of ventral prostate were comparable in the two groups on day 120; however, on day 160, it was lowered in the neonatal exposure group. Subsequently, it became significantly lower in the neonatal exposure group on day 180 ( fig. 2 a) . 
ER ␤ mRNA Concentration
The ER ␤ concentration of ventral prostate in the two groups was similar on day 120; however, on day 160, it was significantly lower in the neonatal exposure group, with the difference being much larger on day 180 ( fig. 2 b) .
Histomorphometry
According to histomorphometry, epithelial components were relatively increased in the exposure group on day 160 ( table 1 ). Malignant changes were not found in any of the rats.
PCNA Staining Cell Ratio
PCNA staining cell ratio was comparable in the two groups on day 120, but it became higher in the neonatal exposure group at day 160 ( table 1 ; fig. 3 ).
Discussion
Neonatal estrogen exposure significantly reduced ventral/BW on days 80 and 180. Tissue and serum testosterone concentrations were significantly lower in the neonatal exposure group on day 120, suggesting the pos-
Control Estrogen
Day 120
Day 160 Fig. 3 . PCNA staining cell ratio in the two groups. The samples were incubated with diluted mouse monoclonal anti-PCNA (PC10). In the PCNA staining cells, the color of the nucleus had changed to yellow (arrows). PCNA staining cell ratio in the two groups was similar on day 120, but it was higher in the neonatal exposure group on day 160. Epithelial components were also increased in the neonatal exposure group on day 160. Magnification ! 400.
sibility that neonatal estrogen exposure might be responsible for decreased levels of testosterone and abnormal estrogen-androgen balance in adulthood. There were some reports about prepubertal and early adult testosterone concentration after neonatal estrogen exposure [9, 11] , but the intimate testosterone concentration in adults still remains to be clarified. Our study results revealed that serum testosterone reached peak levels on day 120 in the control group, but the peak was not seen in the neonatal estrogen exposure group. Contrary to what might be expected, however, the serum testosterone level in the neonatal estrogen exposure group increased after day 160. More precisely speaking, tissue testosterone in the neonatal estrogen exposure group decreased once on day 120 but increased after day 160. It has been reported that continuous testosterone stimulation during the prepubertal period was required for normal development and gland differentiation of the prostate [9] , and administration of testosterone to neonatal estrogen-induced rats during their adulthood was associated with increased levels in the ventral lobes compared with those in nonstimulated rats [9, 11] . Viewed together, there is a possibility that neonatal estrogen exposure might change the environment of testosterone, and as a result enhance cell proliferation and induce glandular hyperplasia in adult rats.
Our results verified that estrogen exposure in the neonatal period results in decreasing ER ␤ in adulthood. It has been documented that neonatal exposure to estrogen was associated with a reduced expression of ER ␤ mRNA in ventral epithelial cells on day 30, and that the decrease became highly significant on day 90 [16] . On the contrary, however, we observed some evidence that the decrease in number of ER ␤ only started in the mature adult, evolving in cell proliferation. In the mature adult, a decrease of ER ␤ is associated with glandular hyperplasia of the prostate. The PCNA expression rate in the rats given estrogen increased, whereas ER ␤ was simultaneously decreased in number, indicating that a decrease in numbers of ER ␤ may contribute to inducing glandular hyperplasia of the prostate. Jarred et al. [22] previously reported that estrogens given during the neonatal period decreased ventral epithelial proportions without any changes in PCNA. Their findings were contradictory to our results; however, we must take into account the fact that their measurements were conducted in vitro and with a short observation period.
In our study, the AR level was significantly lower in the neonatal exposure group on day 180. The serum and tissue testosterone levels in the neonatal estrogen exposure group were decreased on day 120. Accordingly, these findings led to the hypothesis that the decrease in testosterone level during the early adult period might disturb AR elevation when the subjects reach middle age.
Weihua et al. [13] anticipated that ER ␤ might control AR as their findings showed that ER ␤ -KO mice possessed high AR levels. Recently, however, it was documented that neonatal estrogen exposure exerted downregulation of the prostatic androgen receptor through a proteosome-mediated protein degeneration pathway [23] . It is still unclear whether the effects of estrogens on AR degradation in vivo are mediated directly through ER ␤ or indirectly through an intermediary signal. No one can rule out the possibility that ER ␤ is involved in AR regulation; however, the present study could not provide any plausible interpretation about the mechanism.
Other studies implied another mechanism how neonatal estrogen exposure leads to the occurrence of glandular hyperplasia. Some investigators reported that rats exposed to estrogen during their neonatal period presented hyperprolactinemia [24, 25] , together with advancing a mechanism involved in the progress of lymphocyte infiltration of prostatic tissue to glandular hyperplasia via chronic inflammation [26] . It was also reported that neonatal estrogenization was mediated through ER ␣ [27] . Neonatal estrogen exposure causes upregulation of ER ␣ mRNA and protein within the periductal stromal cells along the entire length of the developing ducts, resulting in amplification of estrogen signals in these stromal cells [28] . Given that ER ␣ is not expressed in prostatic epithelial cells, it is postulated that other intermediary signals may be involved in inducing AR degradation in the prostatic epithelium. Recent experimental evidence corroborates deregulation of overlapping signal transduction pathways involving transforming growth factor-␤ (TGF-␤ 1) and epidermal growth factor as well as disruption of cell attachment to the extracellular matrix and subsequent induction of anoikis [29] . Several critical developmental genes were found including the homeobox genes Hox-13 and Nkx3.1 as well as secreted ligands Shh, fibroblast growth factor (FGF)-10, and bone morphogenetic protein (BMP)-4 [30] . Through investigating autocrine and paracrine factors, we will be able to understand how ER ␤ is implicated in the overlapping signal transduction pathways.
Conclusions
Estrogen exposure to Wistar rats in the neonatal period is associated with a decrease in ER ␤ levels in the mature adult and accelerates cell proliferation when the subjects reach middle age. In the mature adult, a decrease in ER ␤ levels facilitates glandular hyperplasia of the prostate. These processes may result in causing differences in individual prostate components.
